Last $29.73 USD
Change Today +0.65 / 2.24%
Volume 243.7K
PCRX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 4:00 PM 05/23/13 All times are local (Market data is delayed by at least 15 minutes).

Insiders at pacira pharmaceuticals inc (PCRX)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
David Stack 31 RelationshipsChief Executive Officer, President and Director--61

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Fred Middleton M.B.A. 145 Relationships--Sanderling Ventures63
John Longenecker Ph.D. 15 Relationships--HemaQuest Pharmaceuticals, Inc.65
Laura Brege 82 Relationships--Nodality, Inc.54
Paul Hastings 268 Relationships--OncoMed Pharmaceuticals, Inc.52
Gary Pace Ph.D. 85 Relationships--QRxPharma Limited64
Luke Evnin Ph.D. 86 Relationships--Cerimon Pharmaceuticals, Inc.49
Andreas Wicki Ph.D. 23 Relationships--HBM Partners Ltd.54
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCRX:US $29.73 USD +0.65

PCRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Durect Corp $0.89 USD -0.0184
View Industry Companies
 

Industry Analysis

PCRX

Industry Average

Valuation PCRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 22.0x
Price/Book 13.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 17.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIRA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.